HOME › DRUGS › VORICONAZOLE
ACTIVE SUBSTANCE / INN

VORICONAZOLE

Brand name(s): VORICONAZOLE, Vfend, Voriconazole Hikma (previously Voriconazole Hospira), VFEND, Voriconazole Accord
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
Aspergillosis;Candidiasis;Mycoses
ANDA207049
ACTIVE SUBSTANCE
Voriconazole
REGULATORS
FDA · EMA
SPONSORS / MAH
EPIC PHARMA LLC, PF PRISM CV, Hikma Farmaceutica (Portugal) S.A.
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
VORICONAZOLEANDA207049EPIC PHARMA LLCPrescription
VORICONAZOLEANDA210849PHARMOBEDIENTDiscontinued
VFENDNDA021630PF PRISM CVPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VfendPfizer Europe MA EEIGAuthorised19/03/2002Candidiasis;Mycoses;Aspergillosis
Voriconazole Hikma (previously Voriconazole Hospira)Hikma Farmaceutica (Portugal) S.A.Authorised27/05/2015Bacterial Infections and Mycoses;Aspergillosis;Candidiasis
Voriconazole AccordAccord Healthcare S.L.U.Authorised16/05/2013Aspergillosis;Candidiasis;Mycoses

FULL INTELLIGENCE ON VORICONAZOLE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →